Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Johns Hopkins University
With
Olix Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \>/= 18 years
Willing to sign informed consent and authorization of use and disclosure of protected health information
For study group: patients must have a clinical diagnosis of NVAMD
For control group: patients undergoing vitrectomy for macular hole, macular pucker, or vitreomacular traction, vitreous floaters or another condition unrelated to scarring.
You may not be if
Subjects with a retinal condition other than NVAMD in which scarring may occur such as proliferative vitreoretinopathy or retinal detachment.
Clareo Health | Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
